BCAS2, short for Breast Carcinoma Amplified Sequence 2, is a protein encoded by the BCAS2 gene in humans. It is primarily known for its integral role in the splicing of pre-mRNA, a critical step in the maturation of messenger RNA which precedes protein synthesis. The expression of BCAS2 is a finely tuned process within the cell, and alterations in its levels can have a variety of cellular consequences. As a part of the spliceosome complex, BCAS2 is essential for the correct removal of introns from pre-mRNA. Beyond its primary function in splicing, BCAS2 has been implicated in other cellular processes, such as DNA repair mechanisms, which are vital for maintaining genomic stability. Research into BCAS2 has revealed that its expression can be influenced by a variety of internal cellular conditions and environmental stimuli, making it a point of interest for studies on gene expression regulation.
Various chemical compounds have been identified that can potentially induce the expression of proteins like BCAS2. These activators can stimulate cellular pathways, leading to an increase in the transcription and subsequent translation of specific genes. For example, signaling molecules such as hormones can bind to their respective receptors and initiate a cascade of intracellular events culminating in gene activation. Certain polyphenolic compounds, like flavonoids found in plants, can interact with cellular signaling pathways that mobilize transcription factors to the promoters of target genes, including those like BCAS2. Additionally, some small-molecule inhibitors can alter the epigenetic landscape by affecting DNA methylation and histone modification, thereby creating a more favorable context for the transcription of certain genes. Other compounds may act as stressors that trigger a cellular stress response, leading to the upregulation of genes involved in restoring homeostasis and protecting the cell from damage. These activators are significant for their ability to influence gene expression, providing insights into the complex regulatory networks that dictate cellular function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
β-Estradiol may upregulate BCAS2 expression through estrogen receptor-mediated transcriptional activation, initiating a cascade of intracellular events leading to the synthesis of BCAS2 mRNA. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid could stimulate BCAS2 expression by binding to retinoic acid receptors that directly bind to DNA response elements upstream of the BCAS2 gene, initiating its transcription. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
This compound might enhance BCAS2 expression as part of cellular defense mechanisms by activating antioxidant response elements in the promoter region of genes including BCAS2. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $70.00 $160.00 $290.00 | 2 | |
Cholecalciferol could upregulate BCAS2 through the vitamin D receptor, with the receptor-ligand complex binding to vitamin D response elements in the BCAS2 gene promoter, stimulating its expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate could induce an increase in BCAS2 expression by inhibiting histone deacetylases, which results in hyperacetylation of histones near the BCAS2 gene, easing transcriptional activation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol might stimulate BCAS2 expression by activating sirtuin pathways that lead to deacetylation of transcription factors or coactivators involved in the transcription of the BCAS2 gene. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride could enhance BCAS2 expression by inhibiting GSK-3, which in turn may activate β-catenin signaling and lead to the transcriptional activation of Wnt target genes including BCAS2. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $30.00 $60.00 $93.00 | 27 | |
Hydrogen peroxide may upregulate BCAS2 expression by creating oxidative stress that activates transcription factors such as NF-κB, which then bind to the BCAS2 promoter and stimulate its transcription. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone is known to upregulate genes through glucocorticoid receptor activation; it could bind to glucocorticoid response elements in the BCAS2 promoter region, leading to increased BCAS2 transcription. | ||||||